Morgan Stanley

13F Holdings History for ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB)

Symbol: ANAB on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 1.85M shares
Security Ownership: 6.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in ANAPTYSBIO, INC Common Stock, par value $0.001 per share (ANAB)

2025-08-05 - Morgan Stanley has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.85M shares of ANAPTYSBIO, INC Common Stock, par value $0.001 per share (ANAB). This represents 6.3% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	6.3%		$37M	1.85M			$20.03	13G	6/30/2025	5 Aug 2025 11:31:51

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	+0%	$41.5M	1.87M	+1,365,204	+271%	$22.20	Q2 2025
3/31/2025	0%	+0%	$9.38M	505K	+288,719	+100%	$18.59	Q1 2025
12/31/2024	0%	+0%	$2.86M	216K	+38,535		$13.24	Q4 2024
9/30/2024	0%	+0%	$5.94M	177K	+85,614		$33.50	Q3 2024
6/30/2024	0%	0%	$2.3M	91.8K	-544,346		$25.06	Q2 2024
3/31/2024	0%		$14.3M	636K			$22.52	Q1 2024
12/31/2023	0%		$12.9M	602K			$21.42	Q4 2023
9/30/2023	0%	+0%	$1.45M	81K	+9,369	+13.1%	$17.96	Q3 2023
6/30/2023	0%	0%	$1.46M	71.6K	-27,012	-27.4%	$20.34	Q2 2023
3/31/2023	0%	+0%	$2.15M	98.6K	+2,714	+2.83%	$21.76	Q1 2023
12/31/2022	0%	0%	$2.97M	95.9K	-11,643	-10.8%	$30.99	Q4 2022
9/30/2022	0%	0%	$2.74M	108K	-39,090	-26.7%	$25.51	Q3 2022
6/30/2022	0%	+0%	$2.98M	147K	+41,664	+39.7%	$20.29^*	Q2 2022
3/31/2022	0%	+0%	$2.6M	105K	+32,264	+44.4%	$24.74^*	Q1 2022
12/31/2021	0%	+0%	$2.53M	72.7K	+775	+1.08%	$34.75	Q4 2021
9/30/2021	0%	0%	$1.95M	71.9K	-89,729	-55.5%	$27.12	Q3 2021
6/30/2021	0%	+0%	$4.19M	162K	+2,136	+1.34%	$25.92	Q2 2021
3/31/2021	0%	+0%	$3.44M	160K	+137,996	+641%	$21.55	Q1 2021
12/31/2020	0%	+0%	$463K	21.5K	+14,093	+189%	$21.49	Q4 2020
9/30/2020	0%	0%	$109K	7.45K	-11,946	-61.6%	$14.63	Q3 2020
6/30/2020	0%	0%	$434K	19.4K	-484,698	-96.2%	$22.38	Q2 2020
3/31/2020	0%	0%	$7.12M	504K	-544,171	-51.9%	$14.13	Q1 2020
12/31/2019	0%	+0%	$17M	1.05M	+843,306	+411%	$16.25	Q4 2019
9/30/2019	0%	+0%	$7.17M	205K	+193,096	+1628%	$34.99	Q3 2019
6/30/2019	0%	+0%	$670K	11.9K	+784	+7.08%	$56.48	Q2 2019
3/31/2019	0%	0%	$809K	11.1K	-144,453	-92.9%	$73.02	Q1 2019
12/31/2018	0%	+0%	$9.92M	156K	+121,669	+359%	$63.79	Q4 2018
9/30/2018	0%	0%	$3.38M	33.9K	-7,209	-17.6%	$99.78	Q3 2018
6/30/2018	0%	+0%	$2.92M	41.1K	+3,523	+9.38%	$71.02	Q2 2018
3/31/2018	0%	-0.01%	$3.91M	37.5K	-285,845	-88.4%	$104.08	Q1 2018
12/31/2017	0.01%	+0.01%	$32.6M	323K	+307,782	+1971%	$100.72	Q4 2017
9/30/2017	0%	+0%	$546K	15.6K	+10,548	+208%	$34.97	Q3 2017
6/30/2017	0%	0%	$121K	5.06K	-6,096	-54.6%	$23.89	Q2 2017
3/31/2017	0%	+0%	$310K	11.2K	+11,160	NEW	$27.78	Q1 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.